MONDELEZ INTERNATIONAL INC-A (MDLZ)
US6092071058 - Common Stock
Taking everything into account, MDLZ scores 5 out of 10 in our fundamental rating. MDLZ was compared to 90 industry peers in the Food Products industry. MDLZ has an excellent profitability rating, but there are some minor concerns on its financial health. MDLZ is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year MDLZ was profitable.
MDLZ had a positive operating cash flow in the past year.
In the past 5 years MDLZ has always been profitable.
In the past 5 years MDLZ always reported a positive cash flow from operatings.
1.2 Ratios
MDLZ has a Return On Assets of 5.29%. This is in the better half of the industry: MDLZ outperforms 67.42% of its industry peers.
With a decent Return On Equity value of 13.70%, MDLZ is doing good in the industry, outperforming 71.91% of the companies in the same industry.
MDLZ has a better Return On Invested Capital (8.68%) than 80.90% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MDLZ is below the industry average of 8.93%.
The last Return On Invested Capital (8.68%) for MDLZ is above the 3 year average (6.55%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.29% | ||
| ROE | 13.7% | ||
| ROIC | 8.68% |
ROA(3y)5.72%
ROA(5y)5.7%
ROE(3y)14.27%
ROE(5y)14.03%
ROIC(3y)6.55%
ROIC(5y)6.31%
1.3 Margins
MDLZ has a Profit Margin of 10.56%. This is amongst the best in the industry. MDLZ outperforms 86.52% of its industry peers.
MDLZ's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 17.18%, MDLZ belongs to the top of the industry, outperforming 92.13% of the companies in the same industry.
In the last couple of years the Operating Margin of MDLZ has remained more or less at the same level.
Looking at the Gross Margin, with a value of 38.77%, MDLZ belongs to the top of the industry, outperforming 93.26% of the companies in the same industry.
In the last couple of years the Gross Margin of MDLZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.18% | ||
| PM (TTM) | 10.56% | ||
| GM | 38.77% |
OM growth 3Y0.4%
OM growth 5Y0.42%
PM growth 3Y0.97%
PM growth 5Y1.49%
GM growth 3Y-0.93%
GM growth 5Y-0.86%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MDLZ is still creating some value.
Compared to 1 year ago, MDLZ has less shares outstanding
MDLZ has less shares outstanding than it did 5 years ago.
MDLZ has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.51 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
MDLZ has a Altman-Z score of 2.51. This is comparable to the rest of the industry: MDLZ outperforms 52.81% of its industry peers.
MDLZ has a debt to FCF ratio of 5.35. This is a neutral value as MDLZ would need 5.35 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.35, MDLZ is doing good in the industry, outperforming 68.54% of the companies in the same industry.
A Debt/Equity ratio of 0.65 indicates that MDLZ is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.65, MDLZ is in line with its industry, outperforming 42.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.35 | ||
| Altman-Z | 2.51 |
ROIC/WACC1.13
WACC7.66%
2.3 Liquidity
A Current Ratio of 0.63 indicates that MDLZ may have some problems paying its short term obligations.
MDLZ has a Current ratio of 0.63. This is amonst the worse of the industry: MDLZ underperforms 86.52% of its industry peers.
MDLZ has a Quick Ratio of 0.63. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MDLZ (0.42) is worse than 82.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.42 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 13.75% over the past year.
Measured over the past 5 years, MDLZ shows a small growth in Earnings Per Share. The EPS has been growing by 6.38% on average per year.
The Revenue has been growing slightly by 2.13% in the past year.
Measured over the past years, MDLZ shows a small growth in Revenue. The Revenue has been growing by 6.79% on average per year.
EPS 1Y (TTM)13.75%
EPS 3Y8.1%
EPS 5Y6.38%
EPS Q2Q%20.73%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y10.66%
Revenue growth 5Y6.79%
Sales Q2Q%1.94%
3.2 Future
MDLZ is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.39% yearly.
MDLZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.04% yearly.
EPS Next Y7.55%
EPS Next 2Y2.8%
EPS Next 3Y5.87%
EPS Next 5Y6.39%
Revenue Next Year1.5%
Revenue Next 2Y2.94%
Revenue Next 3Y3.34%
Revenue Next 5Y4.04%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
MDLZ is valuated rather expensively with a Price/Earnings ratio of 17.80.
MDLZ's Price/Earnings ratio is a bit cheaper when compared to the industry. MDLZ is cheaper than 70.79% of the companies in the same industry.
MDLZ is valuated rather cheaply when we compare the Price/Earnings ratio to 28.96, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.52, which indicates a rather expensive current valuation of MDLZ.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than 67.42% of the companies in the same industry.
MDLZ is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.8 | ||
| Fwd PE | 18.52 |
4.2 Price Multiples
MDLZ's Enterprise Value to EBITDA ratio is in line with the industry average.
MDLZ's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.41 | ||
| EV/EBITDA | 13.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)2.36
PEG (5Y)2.79
EPS Next 2Y2.8%
EPS Next 3Y5.87%
5. Dividend
5.1 Amount
MDLZ has a Yearly Dividend Yield of 2.87%.
MDLZ's Dividend Yield is a higher than the industry average which is at 3.80.
MDLZ's Dividend Yield is a higher than the S&P500 average which is at 2.23.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
5.2 History
The dividend of MDLZ is nicely growing with an annual growth rate of 11.47%!
MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.47%
Div Incr Years10
Div Non Decr Years10
5.3 Sustainability
60.30% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP60.3%
EPS Next 2Y2.8%
EPS Next 3Y5.87%
MONDELEZ INTERNATIONAL INC-A
NASDAQ:MDLZ (11/21/2024, 8:00:01 PM)
After market: 64.69 -0.1 (-0.15%)64.79
+0.37 (+0.57%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap86.64B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.8 | ||
| Fwd PE | 18.52 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.36
PEG (5Y)2.79
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.29% | ||
| ROE | 13.7% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 17.18% | ||
| PM (TTM) | 10.56% | ||
| GM | 38.77% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.42 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)13.75%
EPS 3Y8.1%
EPS 5Y
EPS Q2Q%
EPS Next Y7.55%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.13%
Revenue growth 3Y10.66%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y